Skip to main content

Short Reads/Fingerprints: Jul 1, 2003

Premium

There is life after InforMax. Andrew Whiteley, who took over the reins at the bioinformatics company not long before its acquisition by Invitrogen, has surfaced as president and CEO of Vitra Bioscience, a Sunnyvale, Calif.-based drug discovery firm.

 

Gene Logic snared a potentially super-valuable asset for its TherImmune Research subsidiary: Anne Pilaro, former expert toxicologist in the Center for Biologics Evaluation and Research at the FDA. Pilaro, the new senior director for regulatory affairs, will no doubt rely on her 10 years at FDA to help the company in its push to improve drug discovery and development.

 

Bob Ellis has gotten around. Once the president of startup Genometrix, he joined Affymetrix as an executive vice president about a year and a half ago. Now, Ellis moved to Woburn, Mass.’s BioTrove, a biotech company working with micro- and nanoscale engineering, as COO.

 

Steve Newby may finally be able to take off his sunglasses and fedora when he mingles with the genomics crowd. The leader of the notoriously ill-performing genomics-only mutual fund has been replaced by Robert Sullivan, chief investment officer of Satuit Capital Management.

Genome Canada chose Alex Mackenzie as veep of research, effective at the start of this month. Mackenzie, who was a director of the research institute at the Children’s Hospital of Eastern Ontario and a professor at the University of Ottawa, will be the primary liaison working with scientists involved in Genome Canada initiatives.

 

Gerard Wills left his post as CFO of Nanogen. In the meantime, David Ludvigson, formerly of Argonaut Technologies and Matrix Pharmaceuticals, was appointed executive VP and will serve as CFO.

 

Orchid BioSciences filled Dale Pfost’s old slot with new CEO Paul Kelly. Kelly was previously CEO of Gemini Genomics and helped found Nanovis and AgaMatrix.

 

Anthony Shuber, CTO of Exact Sciences, received an award from the Colorectal Cancer Network for his development of a DNA-based cancer screening test.

 

TIGR''s Claire Fraser and Mitchell Sogin, director of the Josephine Bay Paul Center, will be heading up a four-week class called Advances in Genome Technology and Bioinformatics, which will take place at the Marine Biological Laboratory at Woods Hole this October. Topics will include HTP data analysis and gene expression profiling.

 

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.